News briefing: 10 years later, teplizumab gets a second shot at an FDA OK; J&J files for ...

Retrieved on: 2021-01-04 16:01:45

Tags for this article:

Click the tags to see associated articles and topics

News briefing: 10 years later, teplizumab gets a second shot at an FDA OK; J&J files for .... View article details on hiswai:

Excerpt

The pipeline also includes CLN-049, a bispecific antibody targeting FLT3 and CD3 for the treatment of AML, and CLN-619, a monoclonal antibody ...

Article found on: endpts.com